Develop antibodies with guaranteed high-affinity for your specific application
From diagnostic antibody development to research applications, our scientists tailor each project to your target, intended use and performance requirements.
Get a quoteTalk to our experts
Monoclonal & polyclonal
Choose the antibody format that fits your project and needs best.
11 guaranteed applications
Get antibodies with guaranteed performances for 11 diagnostic applications.
Test in your own lab
Receive the best clones and test them under your conditions. You only pay the full price when you are satisfied.
Choose your Path
Choose your end goal to explore the antibody solutions best suited to your project.
Explore antibody development solutions tailored to your diagnostic target and assay requirements.
Explore custom antibody solutions for experimental detection, characterization and downstream production.
Diagnostic antibody development
Choose the right diagnostic antibody production strategy for your target, assay, timeline and budget.
The star methods for diagnostics :
Monoclonal
Explore Hybridoma Development →
Monoclonal
Explore Single B-Cell Sorting →
Polyclonal
Explore Polyclonal Production →
Alternatives for toxic or low-immunogenic antigens :
In vitro
High-throughput screening using proprietary human, cancer and auto-immune libraries.
Difficult diagnostic targets · Fast screening
Explore Phage Display Production →
AI discovery
Rapid discovery, with antibody sequences generated in just 2–3 days
Any species · No immunization
Not sure which technique is best?
Answer a few questions about your target, timeline and budget to identify the most suitable approach.
Diagnostic antibody services
ProteoGenix guarantees optimal performances for monoclonal antibodies in these 11 applications.
Standard ELISA
Sandwich ELISA
Flow cytometry (FACS)
Immunohistofluorescence
Immunofluorescence
Lateral flow assay (LFA)
Competitive ELISA
Immunoprecipitation
Modification-specific detection
Western Blot
Immunohistochemistry
Reduce project risk
You test the custom monoclonal antibodies under your own experimental conditions before validating the final delivery. Only pay in full for antibodies that work where you need them.
01
Selected antibodies are assessed according to the agreed application requirements.
02
You evaluate the selected antibodies under your actual experimental conditions.
03
You only pay the full project fee if you are satisfied.
Research antibody solutions
Develop, produce or customize antibodies for your experimental needs — from target detection to protein characterization.
Modification-specific research
Develop modification-specific antibodies for cell signaling, protein structure and function, and other research applications.
Explore anti-PTM antibodies →
Downstream production
Produce full-length antibodies or recombinant formats including Fab, scFv and VHH, tailored to your project requirements.
Explore recombinant antibody production →
Research applications
- ELISA
- Western Blot
- Flow Cytometry
- Immunofluorescence
- Immunoprecipitation
- IHC
Dynamic Metabolic Control (DMC) needed a highly specific antibody to detect its DAS+4 tag, a synthetic peptide used to trigger on-demand degradation of target enzymes in its metabolic engineering platform.
The key challenge: discriminating the synthetic tag from closely related native bacterial sequences. ProteoGenix developed a hybridoma-based anti-DAS+4 antibody enabling reliable quantification by Western blot and ELISA.
Choose the right antibody format
The right format depends on your target, intended application, performance requirements, timeline and budget.
Perfect for: Developing IVD diagnostics where reproducibility, high specificity, and regulatory readiness are critical.
Perfect for: Budget-friendly, fast discovery, and broad sensitivity.
Rabbit immunization is often the preferred strategy for diagnostic antibody development, particularly for challenging antigens that are difficult to target in rodents.
From optimization to production and labeling, continue your diagnostic or research project with the services you need for the next development stage.
Enhance antibody developability to achieve IVD-grade quality.
Explore antibody optimization →
Produce the necessary antibody quantities needed for your development stage or lab experiments.
Explore recombinant production →
Enable direct detection and visualization of antibody-antigen interactions.
Explore antibody labeling →
“They adapted protocols to fit our budget without compromising quality. ProteoGenix’s degradation assay was a game-changer, giving us confidence in the antibodies’ specificity. Adjustments to immunization and antibody screening pipelines, along with regular GO/No-GO checkpoints and proactive communication, kept us confident and well-informed throughout the process.”
Dr. Robert Diez, COO
TELUM Therapeutics
“The key benefit of partnering with ProteoGenix was being able to hold scientific discussions with their expert team to explore the overall approach and methods, versus the ‘one size fits all’ approach offered by other providers.”
Michele Dilizia, Chief Scientific Officer and Co-Inventor
Recce Pharmaceuticals
“ProteoGenix has been an outstanding partner, with a customer service team that is responsive, knowledgeable, and genuinely invested in our projects.
The delivered antibody consistently shows excellent sensitivity and specificity, delivering robust, reproducible signals with minimal background across both ELISA and Western blot applications.
Combined with very competitive pricing and staying true to timeline obligations, ProteoGenix offers exceptional value, and we highly recommend them to any lab seeking reliable, bespoke, high-quality antibodies.”
Dakota Ward, PhD, Scientist II
DMC Biotechnologies
SCIENTIFIC PUBLICATIONS
PC Maity et al., IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling. PNAS 117, (8) 4320-27 (2020).
N Yacov et al., MOSPD2 is a therapeutic target for the treatment of CNS inflammation. Clin Exp Imm 201, (2) 105-20 (2020).
A Surribas et al., Monoclonal antibody-based immunosensor for the electrochemical detection of chlortoluron herbicide in groundwaters. Biosensors 11, (12) 513 (2021).
